2023 updated MASCC/ESMO Consensus recommendations: prevention of nausea and vomiting following moderately emetic risk antineoplastic agents

Review the literature to update the MASCC guidelines from 2015 for controlling nausea and vomiting with systemic cancer treatment of moderate emetic potential.

Saved in:

Bibliographic Details
Main Authors:	Scotté, Florian (Author) , Schwartzberg, Lee (Author) , Iihara, Hirotoshi (Author) , Aapro, Matti (Author) , Gralla, Richard J. (Author) , Hesketh, Paul J. (Author) , Jordan, Karin (Author) , Chow, Ronald (Author) , Herrstedt, Jørn (Author)
Corporate Authors:	Multinational Association of Supportive Care in Cancer (Editor) , European Society for Medical Oncology (Editor)
Format:	Article (Journal)
Language:	English
Published:	2024
In:	Supportive care in cancer Year: 2023, Volume: 32, Issue: 1, Pages: 45$p1-9
ISSN:	1433-7339
DOI:	10.1007/s00520-023-08222-3
Subjects:	Übelkeit
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00520-023-08222-3
Author Notes:	Florian Scotté, Lee Schwartzberg, Hirotoshi Iihara, Matti Aapro, Richard Gralla, Paul J. Hesketh, Karin Jordan, Ronald Chow, Jørn Herrstedt

Description
Summary:	Review the literature to update the MASCC guidelines from 2015 for controlling nausea and vomiting with systemic cancer treatment of moderate emetic potential.
Item Description:	Published online 20 December 2023 Gesehen am 04.11.2024
Physical Description:	Online Resource
ISSN:	1433-7339
DOI:	10.1007/s00520-023-08222-3